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Abstract. Considering that obstructive sleep apnea syndrome (OSAS) is usually associated with endothelial dysfunction,
atherosclerosis and cardiovascular disorders, our aim was to examine the erythrocyte deformability and the oxidative status
in a group of OSAS subjects. We consecutively enrolled 48 subjects with OSAS defined after a 1-night cardiorespiratory
sleep study, subsequently subdivided according to the apnea/hypopnea index (AHI) value in two subgroups: Low (L = 21
subjects with AHI<30) and High (H = 27 subjects with AHI>30). We evaluated the erythrocyte deformability, expressed
as elongation index (EI) and the parameters of the oxidative status, such as lipid peroxidation (expressed as thiobarbituric
acid-reactive substances – TBARS) and protein oxidation (measured as carbonyl groups – PC). In the entire group and in the
two subgroups of OSAS subjects we found a decreased erytrocyte deformability at all shear stresses, not correlated with the
plasmatic oxidative stress nor with the polysomnographic parameters. Lipid peroxidation was increased in the whole group
and in the H subgroup of OSAS while protein oxidation showed a different trend. As in OSAS the osmotic fragility and
the metabolism of the red cells seem to be not impaired, the oxidative damage to the red cell membrane proteins might be
responsible for the reduced erythrocyte deformability. This rheological alteration, in addition to the increase in whole blood
and plasma viscosity and to the erythrocyte hyperaggregation, could influence the microcircolatory profile in OSAS subjects.
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1. Introduction
Obstructive sleep apnea syndrome (OSAS) is characterized by repeated partial or complete obstruc-
tions of upper airways, usually occurring at the level of the oropharynx, during sleep with resulting
apnea or hypopnea, with consequent intermittent arterial oxygen desaturation and sleep disruption
[11]. The intermittent hypoxemia can increase sympatetic tone, oxidative stress, pro-inflammatory
cytokine production, platelet aggregation, and metabolic dysregulation [15]. OSAS is significantly
and independently associated with an increased risk of cardiovascular diseases, cerebrovascular events
and all-cause mortality and the incidence of cardiovascular events seems to be related to OSAS severity
[32]. Subjects with severe untreated OSAS have an higher incidence of fatal and non fatal cardiovas-
cular events in comparison with simple snorers or OSAS patients treated with cPAP [18]. Yaggi et al.
[33] demonstrated that OSAS subjects had a 2-fold increased risk of stroke and this association was
independent from other cardiovascular and cerebrovascular risk factors, such as hypertension. Some
papers have evaluated the effects of OSAS on blood rheology. Chin et al. [3] showed increased levels of
fibrinogen and hematocrit in the morning in a small group of OSAS subjects, suggesting an increment
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in blood viscosity. Also Nobili et al showed an increased plasma fibrinogen, which was correlated with
AHI value and with nocturnal minimal oxygen saturation (SO2), and an increased blood viscosity [20].
Tazbirek et al found elevated blood viscosity and erythrocyte aggregation in obese men with OSAS
in comparison with those without OSAS [29]. However, other authors [9] observed an increase only
in plasma viscosity, inversely correlated with mean nocturnal SO2, but no modification of erythrocyte
deformability (evaluated with filtration techniques). Peled et al demonstrated that in OSAS subjects the
increased erythrocyte aggregation is correlated with PCR levels [22], while Sinnapah et al. [25] found
a correlation between erythrocyte aggregation and AHI and between erythrocyte aggregation and BMI
in overweight OSAS subjects. This last paper suggested that BMI is more predictive of erythrocyte
aggregation than AHI and that overweight influences blood rheology more than OSAS severity [25].
The treatment with continuous positive airways pressure (cPAP) during the sleep reduces plasma
fibrinogen [3], and blood and plasma viscosity [29] improving the blood rheological properties. Rein-
hart et al. observed a significant reduction of plasma viscosity and platelet activation after six months
of cPAP therapy [23], while other authors demonstrated an improvement in hematocrit values, blood
viscosity and platelet aggregation after only 30 days of treatment [34].
Keeping in mind all these considerations, our aim was the evaluation of the erythrocyte deformability,
expressed as elongation index (EI), and especially the analysis of the influence of the polysomno-
graphic parameters, of the lipid peroxidation and of the protein oxidation on this determinant of the
hemorheological profile in our group of OSAS subjects.
2. Subjects
We examined 48 subjects (36 men and 12 women; mean age 50.3 ± 14.68 yrs) with obstructive
sleep apnea from those with suspected OSAS referred to our center. Clinical history and physical
examination were performed in all subjects and Epworth Sleepiness Scale (ESS) was also given. OSAS
was diagnosed after a 1-night cardiorespiratory sleep study and its severity was assessed evaluating the
apnea/hypopnea index (AHI); we also defined the oxygen desaturation index (ODI) and the nocturnal
mean oxygen saturation (mSO2). OSAS subjects were subdivided according to the AHI value in two
subgroups: Low (L = 21 subjects with AHI <30) and High (H = 27 subjects with AHI >30), therefore
the Low subgroup included subjects with mild to moderate OSAS, while the H subgroup included the
subjects with severe OSAS. The mean age in the L subgroup was 45.3 ± 14.4, while in the H subgroup
was 52.8 ± 14.2 yrs. The mean ESS score in the entire group of OSAS subjects was 11.1 ± 5.1, in
the L subgroup was 9.2 ± 3.7, while in the H subgroup was 12.4 ± 5.6. Means and S.D. of BMI,
waist circumference, neck circumference, and polysomnographic parameters are reported in Table 1
(Table 1). All the subjects gave their informed consent before entering the study and the study was
approved by the Ethical Committee.
3. Methods
Venous blood samples were collected in the morning by venous puncture from the antecubital vein of
fasting subjects and immediately transferred to anticoagulated glass tubes for evaluation of erythrocyte
deformability, lipid peroxidation and protein oxidation.
3.1. Elongation index (EI)
To evaluate erythrocyte deformability, we mixed 30l of anticoagulated blood with 2 ml of dextran
solution at a viscosity of 24 mPa. The measurement was obtained by using the diffractometer Rheodyn
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Table 1
Mean ± S.D. of age, anthropometric characteristics and OSAS parameters in the entire group of OSAS patients and in the
two subgroups with respectively mild and severe disease
All OSAS patients L subgroup H subgroup
Anthropometric characteristics
BMI (kg/m2) 35.4 ± 7.3 35.7 ± 8.5 35.1 ± 6.5
Waist circumference (cm) 118.8 ± 16.1 114.2 ± 14.5 122.5 ± 16.6
Neck circumference (cm) 44.4 ± 4.5 41.5 ± 3.2 46.6 ± 4.1
Polysomnographyc parameters
AHI 38.5 ± 25.7 15.1 ± 8.1 56.6 ± 18.9
mSO2 (%) 91.1 ± 3.7 93.4 ± 2.7 89.5 ± 3.4
ODI 39.3 ± 29.0 14.3 ± 9.4 55.4 ± 25.7
§p < 0.001 vs L subgroup (Student’s t test for unpaired data). BMI = Body Mass Index. mSO2 = mean oxygen saturation.
AHI = apnea/hypopnea index. ODI = oxygen desaturation index.
SSD of Myrenne, which measures the diffraction pattern of a laser beam passing through erythrocytes
suspended in a viscous medium and deformed by a force with defined shear stress. The shear stresses
employed by us were 6, 12, 30 and 60 Pa. The erythrocyte deformation was expressed as elongation
index (EI) = (l-w/l+w) × 100, were l = length and w = width of the erythrocytes.
3.2. Lipid peroxidation
Lipid peroxidation was evaluated in plasma by detection of thiobarbituric acid-reactive substances
(TBARS), generated by peroxidative processes, which include lipid peroxides and malonildialdehyde.
The evaluation of TBARS was made by fluorimetry, using 1,1,3,3-tetramethoxypropane as standard.
3.3. Protein oxidation
Protein oxidation was evaluated as protein carbonyl groups (PC). The PC groups were measured
by an enzyme-linked immunosorbent assay (ELISA) kit (BioCell PC test kit, Enzo Life Sciences AG,
Switzerland).
Regarding the erythrocyte deformability the control group included 45 subjects (20 women and
25 men, mean age 37.7 ± 7.8 years), while regarding the lipid and protein oxidation the control group
included 59 subjects (16 women and 43 men, mean age 36.2 ± 8.2 years); both the groups of controls
were free of medical diseases as assessed by clinical history, physical examination, electrocardiography,
and routine hematological and urine analysis.
3.4. Statistical analysis
Data were expressed as means ± S.D.; the difference between normal controls and OSAS subjects
was evaluated according to the Student’s t test for unpaired data. The statistical difference between
normal subjects and OSAS subjects subdivided according to the apnea/hypopnea index (AHI) was
estimated using the 1-way analysis of variance (ANOVA) integrated with the Bonferroni test. The
correlations were performed employing the linear regression test. The null hypothesis was rejected for
p values <0.05.
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Table 2
Means ± S.D. of the rheological and oxidative parameters in control subjects and in the entire group of OSAS patients
Control subjects All OSAS patients
EI 6 Pa 27.3 ± 5.7 21.8 ± 4.8§
EI 12 Pa 35.2 ± 5.5 29.9 ± 4.7§
EI 30 Pa 43.0 ± 5.0 39.2 ± 4.3§
EI 60 Pa 46.2 ± 4.5 43.2 ± 3.6#
TBARS (nmol/ml) 5.71 ± 1.42 6.43 ± 1.63∗
PC (nmol/mg prot.) 0.347 ± 0.094 0.316 ± 0.120
∗p < 0.05. #p < 0.01.§ p < 0.001 vs control subjects (Student’s t test). OSAS = Obstructive Sleep Apnea Syndrome.
EI = Elongation Index. TBARS = ThioBarbituric Acid Reactive Substances. PC = Protein Carbonyls.
Table 3
Means ± S.D. of the rheological and oxidative parameters in control subjects and in the two subgroups of OSAS patients
with respectively mild and severe disease
Control subjects L subgroup H subgroup F
EI 6 Pa 27.3 ± 5.7 21.8 ± 5.8# 21.8 ± 4.1§ 10.32a
EI 12 Pa 35.2 ± 5.5 29.9 ± 5.9# 29.9 ± 3.8§ 10.30a
EI 30 Pa 43.0 ± 5.0 38.4 ± 5.2# 39.6 ± 3.7∗ 7.00b
EI 60 Pa 46.2 ± 4.5 42.5 ± 4.4∗ 43.5 ± 3.0∗ 5.86b
TBARS (nmol/ml) 5.71 ± 1.42 5.25 ± 0.47 7.35 ± 1.63§¶ 18.0a
PC (nmol/mg prot.) 0.347 ± 0.094 0.230 ± 0.088 0.382 ± 0.099¶ 16.6a
ap < 0.001. bp < 0.01. (ANOVA). ∗p < 0.05. #p < 0.01.§ p < 0.001 vs control subjects (Bonferroni’s test). ¶p < 0.001 vs L
subgroup (Bonferroni’s test). OSAS = Obstructive Sleep Apnea Syndrome. AHI = Apnea-Hypopnea Index. EI = Elongation
Index. TBARS = ThioBarbituric Acid Reactive Substances. PC = Protein Carbonyls.
4. Results
In the whole group of OSAS subjects we found a decrease in the elongation index at all the shear
stresses in comparison with normal controls (Table 2). In the same group of OSAS we found a signif-
icant increase in lipid peroxidation, while no difference was noted about protein oxidation (Table 2).
Subdividing the entire group of OSAS according to the AHI value we found in the two subgroups
a significant decrease in EI in comparison with normal controls (Table 3), while regarding the lipid
peroxidation we found its increase only in the H subgroup of OSAS subjects and about the protein
oxidation we noted a decrease in the L subgroup and an increase in the H subgroup compared to normal
controls (Table 3).
In the whole group of OSAS subjects no correlation among EI, at all the shear stresses, AHI, mean
nocturnal SO2 and ODI was observed, and the same trend was present in the two subgroups. In the
entire group of OSAS subjects no correlation among EI and lipid peroxidation was noted (Fig. 1) and
the same behavior was evident in the two subgroups. No correlation among elongation index, at all the
shear stresses, and protein oxidation was found in the whole group of OSAS subjects (Fig. 1) nor in
the two subgroups.
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Fig. 1. Correlations between Elongation Index and parameters of oxidative stress in the entire group of OSAS patients.
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5. Discussion
Previously in the same group of OSAS subjects we examined the behavior of the nitric oxide
metabolites and of the erythrocyte deformability [2] as well as the behavior of lipid peroxidation and
protein oxidation [13]. Now therefore our purpose has been to look for some possible mechanisms able
to explain the reduction of erythrocyte deformability in this clinical condition. Our datum concerning
the erythrocyte deformability in OSAS is different from which of other authors [9, 25, 29]. In this brief
report no statistical correlation among erythrocyte deformability and polysomnographic parameters
was observed although others [29] have described a negative correlation between this rheological
parameter and the nocturnal minimal SO2.
In this clinical condition the investigations regarding the osmotic fragility of red cells [21], the
erythrocyte metabolism [9, 17, 21], and the erythrocyte lipid peroxidation [9, 21] have resulted negative
and this finding has directed our attention to the evaluation of extra-erythrocyte factors, such as the
parameters reflecting plasma lipid peroxidation and protein oxidation. In our experience these two
parameters result significantly correlated with the polysomnographic profile in OSAS subjects [13].
However, in the same group of OSAS subjects no correlation between erythrocyte deformability and
plasma lipid peroxidation nor between erythrocyte deformability and plasma protein oxidation has
been demonstrated.
As it is known, the erythrocyte deformability depends on the surface to volume ratio, the internal
viscosity and the membrane dynamic properties [24]. Considering that the internal viscosity is related
especially to the erythrocyte metabolism and that this metabolic aspect results to be normal in OSAS
[9, 17, 21], we must retain that this alteration could be ascribed to the abnormality of the membrane
dynamic properties. These properties depend expecially on the cholesterol/phospholipid ratio, on the
saturated/unsaturated fatty acid ratio, and on the membrane proteins.
The data up to now published underline that in OSAS an alteration of the lipid profile of the ery-
throcyte membrane, expressed as lipid peroxidation, is not present [9, 21] and then it is possible
that the impairment of the erythrocyte deformability might be due to an alteration of the membran
proteins. This first supposition is based on the consideration that OSAS, characterized by short and
repetitive cycles of hypoxia and reoxygenation, activates significantly several inflammatory mecha-
nisms [1, 12] such as CRP, TNF-, IL-8, and IL-6 [7, 10, 14, 19] that may modify the erythrocyte
membrane dynamic properties. Among these biomarkers increased in OSAS we believe that a possi-
ble role may be carried out by IL-8. Up to now in fact there are some data regarding its significant
increase in the membrane of circulating red cells in acute clinical conditions [8, 30] and then an
IL-8 increase could be plausible also in erythrocyte membranes of OSAS subjects. Another hypoth-
esis may regard the possible damage caused by the oxidative stress on these dynamic membrane
properties. Some ROS, such as hydrogen peroxide [26] and superoxide anion [31], seem to influ-
ence the erythrocyte deformability damaging the membrane proteins. As regards, we must underline
that Davies et al. [5, 6] have assured that the oxidative damage of the membrane proteins is a
more sensitive indicator of oxidative stress than lipid peroxidation. The last supposition that could
explain the trend of erythrocyte deformability in OSAS might be identified in the variation of pH
that seems to accompany this syndrome. During the cycles of hypoxia and reoxygenation a con-
dition of respiratory acidosis may also be present and may influence the red cell rheology; there
are many findings regarding the effect of the pH on elastic deformability of the erythrocyte mem-
brane [4, 16], although in our group of OSAS subjects we have no information about the acid-base
balance.
Although it is not easy to ascertain the causes of the decrease of erythrocyte deformability in OSAS,
we must take account of this rheological datum that together with other rheological alterations observed
in this clinical condition, such as the increase in whole blood viscosity [20], especially at morning,
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in plasma viscosity and erythrocyte aggregation [9, 22, 25, 29], delineate a picture of hyperviscosity
syndrome of which must allow considering the prognosis of these subjects.
This research complies with the requirement for ethical publication in Clinical Hemorheology and
Microcirculation as published in Clin Hemorheol Microcirc. 2010;44(1):1-2.
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